[Safety and immunogenicity analysis of recombinant （hansenula polymorpha) hepatitis B vaccine （CpG ODN adjuvant) among adults: the preliminary results of phase I clinical trial]

Clicks: 317
ID: 116827
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Objective: To evaluate the safety and immune effect of recombinant hepatitis B vaccine （CpG ODN adjuvant). Methods: On Oct. 26, 2016, we launched volunteer recruitment in Kaihua county, Quzhou city, Zhejiang Province. In the randomized, double-blind, controlled trial, a total of 48 sub …
Reference Key
zz2020zhonghua[safety Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Liang ZZ;Shao Y;Wang SY;Yan CF;Chen B;Zhang J;Chen YP;Hu XS;Lyu HK;;
Journal zhonghua yu fang yi xue za zhi [chinese journal of preventive medicine]
Year 2020
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/32842315
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine English Abstract pmid:32842315 doi:10.3760/cma.j.cn112150-20200401-00490 z z liang y shao h k lyu

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.